ExpreS2ion Biotech Holding AB’s subsidiary ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) is pleased to announce its participation in two key upcoming events: PepTalk – the Annual Protein Science and Production Week in San Diego, USA, and an Institutional Investor Seminar hosted by HC Andersen Capital in Copenhagen, Denmark.
These events represent important opportunities to showcase ExpreS2ion’s innovative technology platform and exciting development pipeline to scientific and investment audiences. More details, including event registration information, are available on the Company’s website and via the links below. To arrange a meeting at either event, please contact us at info@expreS2ionbio.com.
13-16 January 2025 | PepTalk – Protein Science and Production Week
San Diego, California, USA
PepTalk is a leading conference focused on advancing biotherapeutic discovery and development. On 16 January at 11:30 AM PST, ExpreS2ion’s VP of R&D and Technology, Max Søegaard, will present a talk titled “Advancements in VLP Technology: From Pandemic Countermeasures to Broad-Spectrum Applications in Vaccine Development.” Additional details are available on the Peptalk website.
16 January 2025 | Institutional Investor Seminar
Copenhagen, Denmark
ExpreS2ion’s CEO, Bent Frandsen, will present at an Institutional Investor Seminar hosted by HC Andersen Capital. The presentation will focus on ES2B-C001, ExpreS2ion’s novel therapeutic breast cancer vaccine, which recently received Clinical Trial Application (CTA) approval from Austrian regulatory authorities for a Phase I clinical trial. Nordic institutional investors interested in attending are encouraged to contact HC Andersen Capital for participation details.
[…]